Literature DB >> 11590815

Pathologic assessment of the surgical specimen.

J I Epstein1.   

Abstract

Despite the wealth of information obtained by conventional histology, long-term studies are needed to provide novel information on the correlation of pathologic findings with prognosis. Findings need to be correlated not only with PSA progression but with the more clinically important parameters of distant metastases and survival. Although conventional histology still will have a role in the evaluation of prostate cancer at radical prostatectomy and its correlation with outcome, it undoubtedly will be augmented by newer techniques. These developments must be approached critically and rationally to determine whether they provide additional prognostic information beyond that currently available using more conventional parameters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590815     DOI: 10.1016/s0094-0143(05)70164-6

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  17 in total

1.  Open versus laparoscopic radical prostatectomy.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

2.  Pathologic analysis of capsular and incisional denudation and positive margin status in the development of a robot-assisted laparoscopic prostatectomy program.

Authors:  Stephen B Williams; D E Sutherland; H A Frazier; A Schwartz; J D Engel
Journal:  J Robot Surg       Date:  2009-06-11

3.  Implications of prostate-specific antigen screening guidelines on clinical practice at a Canadian regional community hospital.

Authors:  Todd M Webster; Erika Lau; Ken J Newell
Journal:  Can Urol Assoc J       Date:  2017-08       Impact factor: 1.862

4.  In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.

Authors:  Anthonius J Breeuwsma; Jan Pruim; Maud M Jongen; Albert J Suurmeijer; Wim Vaalburg; Rien J Nijman; Igle J de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-12       Impact factor: 9.236

5.  Cancer Care Ontario Guidelines for radical prostatectomy: striving for continuous quality improvement in community practice.

Authors:  Todd M Webster; Christopher Newell; John F Amrhein; Ken J Newell
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

6.  Management of clinically localized prostate cancer: pathologic processing to robotic prostatectomy.

Authors:  Ashutosh Tewari
Journal:  Rev Urol       Date:  2003

7.  Prostate cancer with bladder neck involvement: pathologic findings with application of a new practical method for tumor extent evaluation and recurrence-free survival after radical prostatectomy.

Authors:  Athanase Billis; Leandro L L Freitas; Luis A Magna; Adil B Samara; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

8.  Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.

Authors:  Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Elizabeth Humphreys; Alan W Partin
Journal:  Prostate       Date:  2008-12-01       Impact factor: 4.104

9.  Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database.

Authors:  J L Nelles; S J Freedland; J C Presti; M K Terris; W J Aronson; C L Amling; C J Kane
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-07-15       Impact factor: 5.554

10.  Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.

Authors:  Jianfeng Xu; Sarah D Isaacs; Jielin Sun; Ge Li; Kathleen E Wiley; Yi Zhu; Fang-Chi Hsu; Fredrik Wiklund; Aubrey R Turner; Tamara S Adams; Wennuan Liu; Bruce J Trock; Alan W Partin; Baoli Chang; Patrick C Walsh; Henrik Grönberg; William Isaacs; Siqun Zheng
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.